Seeing Is Believing
    
                    INZY is currently covered by 5 analysts with an average price target of $14.24. This is a potential upside of $10.24 (256%) from yesterday's end of day stock price of $4.
Inozyme Pharma 's activity chart (see below) currently has 30 price targets and 40 ratings on display. The stock rating distribution of INZY is 91.67% BUY and 8.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 21.43% with an average time for these price targets to be met of 9.29 days.
Highest price target for INZY is $4, Lowest price target is $4, average price target is $4.
Most recent stock forecast was given by TIAGO FAUTH from WELLS FARGO on 19-May-2025. First documented stock forecast 18-Aug-2020.
Currently out of the existing stock ratings of INZY, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$4
5 months 15 days ago
(19-May-2025)
1/2 (50%)
$0.01 (0.25%)
38
Buy
5 months 20 days ago
(14-May-2025)
0/8 (0%)
$18.21 (380.17%)
Buy
6 months 24 days ago
(10-Apr-2025)
0/8 (0%)
$9.77 (230.97%)
Buy
$15
7 months 24 days ago
(10-Mar-2025)
0/5 (0%)
$9.77 (186.81%)
Buy
$40
9 months 21 days ago
(13-Jan-2025)
0/1 (0%)
$22.69 (131.08%)
What is INZY (Inozyme Pharma ) average time for price targets to be met?
Which analyst has the current highest performing score on INZY (Inozyme Pharma ) with a proven track record?
Which analyst has the current lower performing score on INZY (Inozyme Pharma ) with a proven track record?
Which analyst has the most public recommendations on INZY (Inozyme Pharma )?
Which analyst is the currently most bullish on INZY (Inozyme Pharma )?
Which analyst is the currently most reserved on INZY (Inozyme Pharma )?